Name: Quantum Computing in Drug Discovery Market Size 2035
Creator: Roots Analysis
Published: 2026-04-24T00:00:01+05:30
License: https://www.rootsanalysis.com/privacy.html
Keywords: Quantum Computing in Drug Discovery Market, Quantum Computing in Drug Discovery Market Growth, Quantum Computing in Drug Discovery Market Trends, Quantum Computing in Drug Discovery Market Size, Quantum Computing in Drug Discovery Market Share, Quantum Computing in Drug Discovery Market Analysis, Quantum Computing in Drug Discovery Market Forecast, Quantum Computing in Drug Discovery Market Report, Global Quantum Computing in Drug Discovery Market, Quantum Computing in Drug Discovery Industry

Market Size

The quantum computing in drug discovery market, valued at USD 315 million in 2025, is projected to reach USD 361 million in 2026 and USD 1,692 million by 2035, representing a CAGR of 18.7% during the forecast period 2026 to 2035.

Global Quantum Computing in Drug Discovery Market Growth 2025 to 2035

See What’s in the Full Report – Request Your Complimentary Insights!

Market Report: Key Takeaways

Driven by the rising demand for on-premise quantum systems, valued for their speed and efficiency, the hardware segment holds a dominant position in quantum computing in drug discovery market.

Global Quantum Computing in Drug Discovery Market Share by Type of Offering, 2026 and 2035

Your Business is Unique – Why Shouldn’t Your Report Be?

In terms of drug discovery steps, the lead optimization is likely to secure ~50% of the overall revenue share in 2026, due to its significant role in drug discovery process.
In terms of target therapeutic area, currently, oncological disorders capture the largest quantum computing in drug discovery market share (~20%). Due to the rising prevalence of cancer and increased demand for potent anticancer drugs, oncology drug discovery services are in high demand.
In terms of geographical regions, North America captures more than 40% of the market value in the year 2026, due to its strong public and private investments, supportive regulations, and significant funding.

Market Overview

Quantum computing is emerging as a transformative technology in modern drug discovery, enabling researchers to simulate complex molecular interactions with unprecedented precision. This has helped in significantly reducing the time and cost associated with traditional computational methods. By leveraging quantum algorithms and advanced simulation techniques, these systems can analyze chemical spaces that are otherwise intractable for classical computers, which have limited accuracy and require prohibitively long computation times. This integration enhances the efficiency of identifying promising drug candidates, optimizing molecular structures, and predicting biological activity, empowering pharmaceutical companies to develop more effective therapies.

The quantum computing drug discovery sector continues to expand rapidly by leveraging innovations in quantum hardware, software and AI in drug discovery, to improve the accuracy and reduce the timelines of drug discovery. However, the field still faces significant challenges in scaling quantum computing in healthcare applications, including limitations in quantum hardware, error rates, and algorithm stability. Additional hurdles involve selecting appropriate molecular targets, accurately modeling complex biological systems, and integrating quantum workflows with classical computational pipelines.

Achieving cost efficiency and establishing standardized methodologies remain significant hurdles for the widespread adoption of quantum computing in pharma. However, market research reveals that expanding applications in complex disease modeling, molecular simulation, and precision bit are driving momentum in this emerging field. Further, increasing investments in advanced computational technologies and personalized therapeutics further accelerate this growth.

Recent Developments

In February 2026, XtalPi entered into a collaboration with VISEN Pharmaceuticals to co-develop innovative endocrine therapies by integrating quantum physics, AI, and automated experimentation to explore vast chemical spaces.
In February 2026, qBraid and Alpine Quantum Technologies (AQT) signed a product / technology integration agreement in order to make high performance quantum computing more accessible to researchers, developers, and innovators around the world.
In January 2026, Zapata Quantum and University of Maryland announced a research collaboration to demonstrate a fundamentally new approach to building quantum applications grounded in formal verification.

Your Business is Unique – Why Shouldn’t Your Report Be?

Quantum Computing in Drug Discovery Market Trends

Partnerships and Collaborations: Quantum Computing companies are forming numerous partnerships that are driving market growth. For instance, market players, such as QuEra Computing and IonQ have signed 16 and 14 collaborations, respectively, since 2024 to accelerate the development of quantum computing technologies. Similarly, several other market players are entering into collaborations to integrate technologies and advance research in quantum computing for drug discovery.
Grants: In recent years, several research organizations have provided financial support to advance research initiatives in the field of quantum computing for drug discovery. Notably, funding agencies have awarded around 40 grants to various organizations for research related to quantum computing in drug discovery, since 2021. For instance, in March 2026, Kvantify secured USD 8.1 million in funding to scale quantum drug discovery platform named Qrunch.
Growth in Industry Engagement: Quantum computing aided drug discovery has witnessed a surge in number of events, such as conferences, webinars and symposiums. In fact, players are proactively conducting and participating in events to discuss their research findings related to quantum computing in drug discovery. For instance, IBM recently organized a “Quantum Developer Conference” in which quantum computing developers participated from all over the world.
Growing Emphasis on Logical Qubits: The increasing focus on logical qubit pharma reflects a shift toward building error-corrected quantum systems that can reliably perform complex molecular simulations for drug discovery. This trend aims to overcome hardware limitations by improving stability and scalability, enabling more accurate and commercially viable pharmaceutical research.
Rising Global Demand for Quantum Computing in Drug Discovery: Quantum computing drives the rising global demand through several benefits, such as increased accuracy, reduced timelines of drug discovery, and potential to simulate complex molecular structures precisely.

Industry Experts on Quantum Computing in Drug Discovery Market

Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The market report includes detailed transcripts of interviews conducted with the following individuals:

Chief Executive Officer, Small Organization, US
Quantum Engineer, Small Organization, US

In addition, the market report includes transcripts of the following other third-party discussions:

Manager of Quantum Technologies, Large Organization, Finland
Research Scientist, Very Large Organization, US

Quantum computing in drug discovery domain will mark a turning point in the coming future. Abhay Agarwal, Quantum Engineer, PolarisQB, “Quantum computing is an emerging field, with potential in various domains, such as healthcare, cybersecurity, space science, chemistry and many more. In my opinion, drug discovery and design is one of the key success areas of quantum computing. However, currently the demand for this technology has increased significantly, resulting in unmet needs due to the efficiency perspective”.

Market Drivers

Enhanced Precision: Ongoing advancements in quantum algorithms, such as error correction techniques, deep learning and hybrid quantum-classical models are improving the accuracy and efficiency of molecular simulations in drug discovery. These innovations enable researchers to model complex biochemical interactions at an unprecedented level of detail, leading to more reliable predictions of drug-target binding and behavior. This precision-driven approach is opening new pathways for identifying novel therapeutics and optimizing drug candidates across a wide range of diseases.
Next Generation Simulation Capabilities: The emergence of quantum-enhanced simulation tools is redefining the boundaries of molecular research. As investment in quantum technologies increases, scientists can explore complex biochemical systems with greater precision.
Multi-Modal Quantum Advancements: The development of next-generation hybrid and multi-algorithm quantum computing approaches for drug discovery is poised to significantly accelerate the process by overcoming the limitations of classical computational methods. Leading innovators are exploring integrated frameworks that combine multiple quantum algorithms within a single workflow, enabling the simultaneous optimization of molecular properties, binding affinities, and reaction pathways.

Pay Only for What You Need – The Best Way to Optimize

Market Segmentation Analysis

Oncological Disorders Driving Application of Quantum Computing in Drug Discovery

According to the market forecast, oncological disorders dominate the current market (~20%). Further, it is worth noting that oncological disorders are likely to grow at a higher CAGR (21.1%), showcasing substantial growth potential during the forecast period.
This growth is driven by the rising prevalence of cancer, which is increasing demand for anticancer drugs and fueling ongoing research exploration across a broad range of target indications.

Lead Optimization Driving Quantum Computing in Drug Discovery Market Growth

The global market is segmented across different drug discovery steps, such as target identification / validation, hit generation / lead identification, and lead optimization. The lead optimization step captures majority share (~50%) in 2026.

This growth is driven by the crucial role that lead optimization plays in refining candidate molecules into safe and effective drugs, as well as by the increasing complexity of drug targets and advancements in precision therapies.

Global Quantum Computing in Drug Discovery Market Outlook by Drug Discovery Steps, 2026

Hardware Set to Lead Quantum Computing in Drug Discovery Market

According to the market forecast by type of offering, the hardware segment dominates the current market (50%).
A major driver of the quantum computing hardware segment is the advancement and deployment of scalable quantum processors. Companies such as IBM and Google are leveraging qubit technologies, including superconducting circuits and trapped ions, to build these systems.

Market Regional Insights

North America Dominates the Market

In 2035, North America will likely dominate, capturing more than 40% of the market share. Key factors that contribute to the region’s dominance in this industry include robust partnerships between academia and industry players, and the availability of cutting-edge manufacturing capabilities for advanced quantum computing machines. For instance, IonQ, a US based company, has signed an academic agreement with the Korea Institute of Science and Technology Information (KISTI) to support research and development in this domain. Additionally, it is worth highlighting that in November 2025 the US Department of Energy (DOE) has raised USD 625 million in funding to renew its five National Quantum Information Science (QIS) Research Centers.

Quantum Computing in Drug Discovery Adoption in the Asia Pacific Region

The market in Asia-Pacific is likely to observe a higher annualized growth rate of 21.3% during the forecast period. Notable examples of very large companies providing quantum computing based drug discovery, headquartered in Asia-Pacific include Fujitsu, Huawei and Toshiba. The detailed methodology across the global market and revenue generated across various segments is available in the full report.

Get an Instant Quote in 10 Minutes. Lowest Price Guaranteed

Quantum Computing in Drug Discovery Market: Scope of the Report

Key Report Attributes	Details
Historical Trend	Since 2023
Forecast Period	Till 2035
Market Size 2026	USD 361 Million
Market Size 2035	USD 1,692 Million
CAGR (Till 2035)	18.7%
Key Players	IBM IonQ Microsoft PASQAL Rigetti Computing Riverlane Xanadu Infleqtion Quandela Classiq QuEra Computing D-wave (A complete list of companies captured is available in the report)
Segments Covered	Type of Offering Drug Discovery Step Target Therapeutic Area End User Geographical Regions
Excel Data Packs (Complimentary)	Market Landscape (Software Providers) Market Landscape (Hardware Providers) Company Competitiveness Analysis (Software Providers) Grants Analysis Partnerships and Collaborations Market Forecast and Opportunity Analysis
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization

Market Segments

Based on the research, we have segmented the Quantum Computing in Drug Discovery Market into type of offering, drug discovery steps, target therapeutic area, end user and geographical regions.

By Type of Offering

Hardware
Service
Platform / Software

By Drug Discovery Steps

Target Identification / Validation
Hit Generation / Lead Identification
Lead Optimization

By Target Therapeutic Area

Oncological Disorders
Cardiovascular Disorders
Musculoskeletal Disorders
Neurological Disorders
Respiratory Disorders
Immunological Disorders
Gastrointestinal Disorders
Endocrine Disorders
Ophthalmological Disorders
Blood-related Disorders
Dermatological Disorders
Infectious Diseases
Urinary Disorders

By End User

Pharma and Biotech Companies
CROs
Research and Academic Institutions

By Geographical Regions

North America
- US
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
Middle East and North Africa
- Saudi Arabia
- UAE
- Egypt
Latin America
- Brazil
- Mexico
- Argentina

Table of Contens

+ 1. BACKGROUND

1.1. Context

1.2. Project Objectives

+ 2. RESEARCH METHODOLOGY

2.1. Chapter Overview

2.2. Research Assumptions

2.2.1. Market Landscape and Market Trends

2.2.2. Market Forecast and Opportunity Analysis

2.2.3. Comparative Analysis

2.3. Database Building

2.3.1. Data Collection

2.3.2. Data Validation

2.3.3. Data Analysis

2.4. Project Methodology

2.4.1. Secondary Research

2.4.1.1. Annual Reports

2.4.1.2. Academic Research Papers

2.4.1.3. Company Websites

2.4.1.4. Investor Presentations

2.4.1.5. Regulatory Filings

2.4.1.6. White Papers

2.4.1.7. Industry Publications

2.4.1.8. Conferences and Seminars

2.4.1.9. Government Portals

2.4.1.10. Media and Press Releases

2.4.1.11. Newsletters

2.4.1.12. Industry Databases

2.4.1.13. Roots Proprietary Databases

2.4.1.14. Paid Databases and Sources

2.4.1.15. Social Media Portals

2.4.1.16. Other Secondary Sources

2.4.2. Primary Research

2.4.2.1. Types of Primary Research

2.4.2.1.1. Qualitative Research

2.4.2.1.2. Quantitative Research

2.4.2.1.3. Hybrid Approach

2.4.2.2. Advantages of Primary Research

2.4.2.3. Techniques for Primary Research

2.4.2.3.1. Interviews

2.4.2.3.2. Surveys

2.4.2.3.3. Focus Groups

2.4.2.3.4. Observational Research

2.4.2.3.5. Social Media Interactions

2.4.2.4. Key Opinion Leaders Considered in Primary Research

2.4.2.4.1. Company Executives (CXOs)

2.4.2.4.2. Board of Directors

2.4.2.4.3. Company Presidents and Vice Presidents

2.4.2.4.4. Research and Development Heads

2.4.2.4.5. Technical Experts

2.4.2.4.6. Subject Matter Experts

2.4.2.4.7. Scientists

2.4.2.4.8. Doctors and Other Healthcare Providers

2.4.2.5. Ethics and Integrity

2.4.2.5.1. Research Ethics

2.4.2.5.2. Data Integrity

2.4.3. Analytical Tools and Databases

2.5. Robust Quality Control

+ 3. MARKET DYNAMICS

3.1. Chapter Overview

3.2. Forecast Methodology

3.2.1. Top-down Approach

3.2.2. Bottom-up Approach

3.2.3. Hybrid Approach

3.3. Market Assessment Framework

3.3.1. Total Addressable Market (TAM)

3.3.2. Serviceable Addressable Market (SAM)

3.3.3. Serviceable Obtainable Market (SOM)

3.3.4. Currently Acquired Market (CAM)

3.4. Forecasting Tools and Techniques

3.4.1. Qualitative Forecasting

3.4.2. Correlation

3.4.3. Regression

3.4.4. Extrapolation

3.4.5. Convergence

3.4.6. Sensitivity Analysis

3.4.7. Scenario Planning

3.4.8. Data Visualization

3.4.9. Time Series Analysis

3.4.10. Forecast Error Analysis

3.5. Key Considerations

3.5.1. Demographics

3.5.2. Government Regulations

3.5.3. Reimbursement Scenarios

3.5.4. Market Access

3.5.5. Supply Chain

3.5.6. Industry Consolidation

3.5.7. Pandemic / Unforeseen Disruptions Impact

3.6. Limitations

+ 4. MACRO-ECONOMIC INDICATORS

4.1. Chapter Overview

4.2. Market Dynamics

4.2.1. Time Period

4.2.1.1. Historical Trends

4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage

4.2.2.1. Major Currencies Affecting the Market

4.2.2.2. Factors Affecting Currency Fluctuations on the Industry

4.2.2.3. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Currency Exchange Rate

4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market

4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession

4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt

4.2.5. Inflation

4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy

4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates

4.2.6.1. Interest Rates and Their Impact on the Market

4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis

4.2.7.1. Type of Commodity

4.2.7.2. Origins and Destinations

4.2.7.3. Values and Weights

4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics

4.2.8.1. Import Scenario

4.2.8.2. Export Scenario

4.2.8.3. Trade Policies

4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers

4.2.8.5. Impact of Trade Barriers on the Market

4.2.9. War Impact Analysis

4.2.9.1. Russian-Ukraine War

4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors

4.2.10.1. Global Economic Impact

4.2.10.2. Industry-specific Impact

4.2.10.3. Government Response and Stimulus Measures

4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators

4.2.11.1. Fiscal Policy

4.2.11.2. Consumer Spending

4.2.11.3. Gross Domestic Product

4.2.11.4. Employment

4.2.11.5. Taxes

4.2.11.6. Stock Market Performance

4.2.11.7. Cross Border Dynamics

4.3. Conclusion

+ 5. EXECUTIVE SUMMARY

5.1. Chapter Overview

5.2. Executive Summary: Market Landscape

5.3. Executive Summary: Market Trends

5.4. Executive Summary: Market Forecast and Opportunity Analysis

+ 6. INTRODUCTION

6.1. Overview of Quantum Computing in Drug Discovery

6.2. Principles of Quantum Computing

6.3. Drug Discovery and Development Timeline

6.4. Historical Evolution of Computational Drug Discovery Approaches

6.5. Classification of Quantum Computing Approaches

6.6. Applications of Quantum Computing in Drug Discovery Process

6.7. Advantages of Quantum Computing in Drug Discovery

6.8. Challenges Associated with Quantum Computing in Drug Discovery

6.9. Future Perspectives

+ 7. MARKET LANDSCAPE: SOFTWARE PROVIDERS

7.1. Quantum Computing Software Providers: Overall Market Landscape

7.1.1. Analysis by Year of Establishment

7.1.2. Analysis by Company Size

7.1.3. Analysis by Location of Headquarters

7.1.4. Analysis by Business Capabilities

7.1.5. Analysis by Type of Service Offered

7.1.6. Analysis by Type of Drug Discovery Service Offered

7.1.7. Analysis by Type of Molecule Compatible

7.1.8. Analysis by Compatible Computational Approach

7.1.9. Analysis by Target Therapeutic Area

7.1.10. Analysis by End User

+ 8. COMPANY COMPETITIVENESS ANALYSIS: SOFTWARE PROVIDERS

8.1. Methodology and Key Parameters

8.2. Scoring Criteria

8.3. Peer Groups

8.4. Company Competitiveness Analysis: Players based in North America (Peer Group I)

8.4.1. Overview

8.4.2. 3D Bubble Chart

8.4.3. Companies with Highest Portfolio Strength Score

8.5. Company Competitiveness Analysis: Players based in Europe (Peer Group II)

8.5.1. Overview

8.5.2. 3D Bubble Chart

8.5.3. Companies with Highest Portfolio Strength Score

8.6. Company Competitiveness Analysis: Players based in Asia-Pacific and Rest of the World (Peer Group III)

8.6.1. Overview

8.6.2. 3D Bubble Chart

8.6.3. Companies with Highest Portfolio Strength Score

+ 9. MARKET LANDSCAPE: HARDWARE PROVIDERS

9.1. Quantum Computing Hardware Providers: Overall Market Landscape

9.1.1. Analysis by Year of Establishment

9.1.2. Analysis by Company Size

9.1.3. Analysis by Location of Headquarters

9.1.4. Analysis by Type of Offering

9.1.5. Analysis by Data Storage on Cloud

9.1.6. Analysis by Compatible Computational Approaches

9.1.7. Analysis by Type of Additional Service Offered

+ 10. COMPANY PROFILES: QUANTUM COMPUTING SOFTWARE PROVIDERS

10.1. Chapter Overview

10.2. Quantum Computing Software Providers: Company Profiles

10.2.1. Accenture*

10.2.1.1. Company Overview

10.2.1.2. Management Team

10.2.1.3. Service Portfolio

10.2.1.4. Key Initiatives

* Similar details are presented for other companies mentioned below (based on information in the public domain)

10.2.2. Atos

10.2.3. Eviden

10.2.4. Huawei

10.2.5. Tencent Cloud

10.2.6. Toshiba

+ 11. COMPANY PROFILES: QUANTUM COMPUTING HARDWARE PROVIDERS

11.1. Chapter Overview

11.2. Quantum Computing Hardware Providers: Company Profiles

11.2.1. Amazon Web Series (AWS)*

11.2.1.1. Company Overview

11.2.1.2. Management Team

11.2.1.3. Service Portfolio

11.2.1.4. Key Initiatives

* Similar details are presented for other companies mentioned below (based on information in the public domain)

11.2.2. Fujitsu

11.2.3. Google

11.2.4. IBM

11.2.5. Microsoft

+ 12. GRANTS ANALYSIS

12.1. Chapter Overview

12.1.1. Types of Grant Applications

12.1.2. Prominent Funding Institute Centers

12.1.3. Key Parameters for Consideration

12.1.4. Stages of Grants

12.1.5. Methodology and Key Parameters

12.2. Quantum Computing for Drug Discovery: Grants

12.2.1. Analysis by Year of Grant

12.2.2. Analysis by Amount Awarded

12.2.3. Analysis by Activity Codes

12.2.4. Analysis by Support Period

12.2.5. Analysis by Purpose of Grant

12.2.6. Analysis by Administering Institute Center

12.2.7. Analysis by Type of Organization

12.2.8. Prominent Program Officers: Analysis by Number of Grants

12.2.9. Analysis by Funding Institute Center

12.2.10. Analysis by Type of Grant Application

12.2.11. Analysis by Funding Institute Center and Support Period

12.2.12. Analysis by Location of Recipient Organization

12.2.13. Popular Recipient Organizations: Analysis by Amount Awarded

12.2.14. Popular Recipient Organizations: Analysis by Number of Grants

12.2.15. Summary

+ 13. PARTNERSHIPS AND COLLABORATIONS

13.1. Chapter Overview

13.2. Partnership Models

13.3. Quantum Computing Service Providers: Partnerships and Collaborations

13.3.1. Analysis by Year of Partnership

13.3.2. Analysis by Type of Partnership

13.3.3. Analysis by Year and Type of Partnership

13.3.4. Analysis by Type of Product Involved

13.3.5. Most Active Players: Analysis by Number of Partnerships

13.3.6. Analysis by Geography

13.3.6.1. Local and International Agreements

13.3.6.2. Intracontinental and Intercontinental Agreements

+ 14. EMERGING ROLE OF QUANTUM COMPUTING ACROSS VARIOUS INDUSTRIES

14.1. Overview of Quantum Computing

14.2. Applications of Quantum Computing Across Various Industries

14.3. Upcoming Trends in Quantum Computing

14.4. Future Perspectives

+ 15. BLUE OCEAN STRATEGY

15.1. Overview of Blue Ocean Strategy

15.1.1. Red Oceans

15.1.2. Blue Oceans

15.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy

15.1.4. Quantum Computing in Drug Discovery Market: Blue Ocean Strategy and Shift Tools

15.1.4.1. Value Innovation

15.1.4.2. Strategy Canvas

15.1.4.3. Pioneer-Migrator-Settler (PMS) Map

+ 16. PORTER’S FIVE FORCES ANALYSIS

16.1. Overview

16.1. Significance of Porter’s Five Forces Analysis

16.2. Porter’s Five Forces

16.3. Methodology

16.3.1. Threats of New Entrants

16.3.2. Bargaining Power of Buyers

16.3.3. Bargaining Power of Quantum Computing Providers

16.3.4. Threats of Substitute Products

16.3.5. Rivalry among Existing Competitors

+ 17. GLOBAL QUANTUM COMPUTING IN DRUG DISCOVERY MARKET

17.1. Chapter Overview

17.2. Key Assumptions and Methodology

17.3. Global Quantum Computing in Drug Discovery Market, Historical Trends (since 2023) and Forecasted Estimates (till 2035)

17.3.1. Roots Analysis Perspective on Market Growth

17.3.2. Scenario Analysis

17.3.2.1. Conservative Scenario

17.3.2.2. Optimistic Scenario

17.4. Key Market Segmentations

+ 18. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET, BY TYPE OF OFFERING

18.1. Chapter Overview

18.2. Key Assumptions and Methodology

18.3. Quantum Computing in Drug Discovery Market: Distribution by Type of Offering

18.3.1. Hardware: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

18.3.2. Service: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

18.3.3. Platform / Software: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

18.4. Data Triangulation and Validation

+ 19. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET, BY DRUG DISCOVERY STEP

19.1. Chapter Overview

19.2. Key Assumptions and Methodology

19.3. Quantum Computing in Drug Discovery Market: Distribution by Drug Discovery Step

19.3.1. Target Identification / Validation: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

19.3.2. Hit Generation / Lead Identification: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

19.3.3. Lead Optimization: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

19.4. Data Triangulation and Validation

+ 20. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET, BY TARGET THERAPEUTIC AREA

20.1. Chapter Overview

20.2. Key Assumptions and Methodology

20.3. Quantum Computing in Drug Discovery Market: Distribution by Target Therapeutic Area

20.3.1. Oncological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.2. Cardiovascular Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.3. Musculoskeletal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.4. Neurological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.5. Respiratory Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.6. Immunological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.7. Gastrointestinal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.8. Endocrine Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.9. Ophthalmological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.10. Blood-related Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.11. Dermatological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.12. Infectious Diseases: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.3.13. Urinary Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

20.4. Data Triangulation and Validation

+ 21. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET, BY END USER

21.1. Chapter Overview

21.2. Key Assumptions and Methodology

21.3. Quantum Computing in Drug Discovery Market: Distribution by End User

21.3.1. Pharma and Biotech Companies: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

21.3.2. CROs: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

21.3.3. Research and Academic Institutes: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

21.4. Data Triangulation and Validation

+ 22. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET, BY GEOGRAPHICAL REGIONS

22.1. Chapter Overview

22.2. Key Assumptions and Methodology

22.3. Quantum Computing in Drug Discovery Market: Distribution by Geographical Regions

22.3.1. North America: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.1.1. US: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.1.2. Canada: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.1.3. Puerto Rico: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.2. Europe: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.2.1. UK: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.2.2. Germany: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.2.3. France: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.2.4. Italy: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.2.5. Spain: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.2.6. Rest of Europe: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.3. Asia-Pacific: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.3.1. China: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.3.2. Japan: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.3.3. Australia: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.3.4. South Korea: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.3.5. India: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.4. Middle East and North Africa: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.4.1. Saudi Arabia: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.4.2. UAE: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.4.3. Egypt: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.4. Latin America: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.4.1. Brazil: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.4.2. Mexico: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.3.4.3. Argentina: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

22.4. Market Dynamics Assessment

22.4.1. Market Movement Analysis

22.4.2. Penetration-Growth (P-G) Matrix

22.5. Data Triangulation and Validation

+ 23. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET: NORTH AMERICA

23.1. Quantum Computing in Drug Discovery Market in North America: Distribution by Type of Offering

23.1.1. Quantum Computing in Drug Discovery Market in North America for Hardware: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.1.2. Quantum Computing in Drug Discovery Market in North America for Service: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.1.3. Quantum Computing in Drug Discovery Market in North America for Platform / Software: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.2. Quantum Computing in Drug Discovery Market in North America: Distribution by Drug Discovery Step

23.2.1. Quantum Computing in Drug Discovery Market in North America for Target Identification / Validation: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.2.2. Quantum Computing in Drug Discovery Market in North America for Hit Generation / Lead Identification: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.2.3. Quantum Computing in Drug Discovery Market in North America for Lead Optimization: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3. Quantum Computing in Drug Discovery Market in North America: Distribution by Target Therapeutic Area

23.3.1. Quantum Computing in Drug Discovery Market in North America for Oncological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.2. Quantum Computing in Drug Discovery Market in North America for Cardiovascular Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.3. Quantum Computing in Drug Discovery Market in North America for Musculoskeletal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.4. Quantum Computing in Drug Discovery Market in North America for Neurological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.5. Quantum Computing in Drug Discovery Market in North America for Respiratory Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.6. Quantum Computing in Drug Discovery Market in North America for Immunological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.7. Quantum Computing in Drug Discovery Market in North America for Gastrointestinal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.8. Quantum Computing in Drug Discovery Market in North America for Endocrine Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.9. Quantum Computing in Drug Discovery Market in North America for Ophthalmological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.10. Quantum Computing in Drug Discovery Market in North America for Blood-related Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.11. Quantum Computing in Drug Discovery Market in North America for Dermatological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.12. Quantum Computing in Drug Discovery Market in North America for Infectious Diseases: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.3.13. Quantum Computing in Drug Discovery Market in North America for Urinary Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.4. Quantum Computing in Drug Discovery Market in North America: Distribution by End User

23.4.1. Quantum Computing in Drug Discovery Market in North America for Pharma and Biotech Companies: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.4.2. Quantum Computing in Drug Discovery Market in North America for CROs: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

23.4.3. Quantum Computing in Drug Discovery Market in North America for Research and Academic Institutes: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

+ 24. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET: EUROPE

24.1. Quantum Computing in Drug Discovery Market in Europe: Distribution by Type of Offering

24.1.1. Quantum Computing in Drug Discovery Market in Europe for Hardware: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.1.2. Quantum Computing in Drug Discovery Market in Europe for Service: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.1.3. Quantum Computing in Drug Discovery Market in Europe for Platform / Software: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.2. Quantum Computing in Drug Discovery Market in Europe: Distribution by Drug Discovery Step

24.2.1. Quantum Computing in Drug Discovery Market in Europe for Target Identification / Validation: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.2.2. Quantum Computing in Drug Discovery Market in Europe for Hit Generation / Lead Identification: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.2.3. Quantum Computing in Drug Discovery Market in Europe for Lead Optimization: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3. Quantum Computing in Drug Discovery Market in Europe: Distribution by Target Therapeutic Area

24.3.1. Quantum Computing in Drug Discovery Market in Europe for Oncological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.2. Quantum Computing in Drug Discovery Market in Europe for Cardiovascular Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.3. Quantum Computing in Drug Discovery Market in Europe for Musculoskeletal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.4. Quantum Computing in Drug Discovery Market in Europe for Neurological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.5. Quantum Computing in Drug Discovery Market in Europe for Respiratory Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.6. Quantum Computing in Drug Discovery Market in Europe for Immunological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.7. Quantum Computing in Drug Discovery Market in Europe for Gastrointestinal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.8. Quantum Computing in Drug Discovery Market in Europe for Endocrine Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.9. Quantum Computing in Drug Discovery Market in Europe for Ophthalmological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.10. Quantum Computing in Drug Discovery Market in Europe for Blood-related Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.11. Quantum Computing in Drug Discovery Market in Europe for Dermatological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.12. Quantum Computing in Drug Discovery Market in Europe for Infectious Diseases: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.3.13. Quantum Computing in Drug Discovery Market in Europe for Urinary Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.4. Quantum Computing in Drug Discovery Market in Europe: Distribution by End User

24.4.1. Quantum Computing in Drug Discovery Market in Europe for Pharma and Biotech Companies: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.4.2. Quantum Computing in Drug Discovery Market in Europe for CROs: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

24.4.3. Quantum Computing in Drug Discovery Market in Europe for Research and Academic Institutes: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

+ 25. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET: ASIA-PACIFIC

25.1. Quantum Computing in Drug Discovery Market in Asia-Pacific: Distribution by Type of Offering

25.1.1. Quantum Computing in Drug Discovery Market in Asia-Pacific for Hardware: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.1.2. Quantum Computing in Drug Discovery Market in Asia-Pacific for Service: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.1.3. Quantum Computing in Drug Discovery Market in Asia-Pacific for Platform / Software: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.2. Quantum Computing in Drug Discovery Market in Asia-Pacific: Distribution by Drug Discovery Step

25.2.1. Quantum Computing in Drug Discovery Market in Asia-Pacific for Target Identification / Validation: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.2.2. Quantum Computing in Drug Discovery Market in Asia-Pacific for Hit Generation / Lead Identification: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.2.3. Quantum Computing in Drug Discovery Market in Asia-Pacific for Lead Optimization: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3. Quantum Computing in Drug Discovery Market in Asia-Pacific: Distribution by Target Therapeutic Area

25.3.1. Quantum Computing in Drug Discovery Market in Asia-Pacific for Oncological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.2. Quantum Computing in Drug Discovery Market in Asia-Pacific for Cardiovascular Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.3. Quantum Computing in Drug Discovery Market in Asia-Pacific for Musculoskeletal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.4. Quantum Computing in Drug Discovery Market in Asia-Pacific for Neurological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.5. Quantum Computing in Drug Discovery Market in Asia-Pacific for Respiratory Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.6. Quantum Computing in Drug Discovery Market in Asia-Pacific for Immunological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.7. Quantum Computing in Drug Discovery Market in Asia-Pacific for Gastrointestinal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.8. Quantum Computing in Drug Discovery Market in Asia-Pacific for Endocrine Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.9. Quantum Computing in Drug Discovery Market in Asia-Pacific for Ophthalmological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.10. Quantum Computing in Drug Discovery Market in Asia-Pacific for Blood-related Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.11. Quantum Computing in Drug Discovery Market in Asia-Pacific for Dermatological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.12. Quantum Computing in Drug Discovery Market in Asia-Pacific for Infectious Diseases: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.3.13. Quantum Computing in Drug Discovery Market in Asia-Pacific for Urinary Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.4. Quantum Computing in Drug Discovery Market in Asia-Pacific: Distribution by End User

25.4.1. Quantum Computing in Drug Discovery Market in Asia-Pacific for Pharma and Biotech Companies: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.4.2. Quantum Computing in Drug Discovery Market in Asia-Pacific for CROs: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

25.4.3. Quantum Computing in Drug Discovery Market in Asia-Pacific for Research and Academic Institutes: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

+ 26. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET: MIDDLE EAST AND NORTH AFRICA

26.1. Quantum Computing in Drug Discovery Market in Middle East and North Africa: Distribution by Type of Offering

26.1.1. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Hardware: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.1.2. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Service: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.1.3. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Platform / Software: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.2. Quantum Computing in Drug Discovery Market in Middle East and North Africa: Distribution by Drug Discovery Step

26.2.1. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Target Identification / Validation: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.2.2. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Hit Generation / Lead Identification: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.2.3. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Lead Optimization: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3. Quantum Computing in Drug Discovery Market in Middle East and North Africa: Distribution by Target Therapeutic Area

26.3.1. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Oncological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.2. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Cardiovascular Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.3. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Musculoskeletal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.4. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Neurological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.5. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Respiratory Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.6. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Immunological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.7. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Gastrointestinal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.8. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Endocrine Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.9. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Ophthalmological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.10. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Blood-related Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.11. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Dermatological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.12. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Infectious Diseases: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.3.13. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Urinary Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.4. Quantum Computing in Drug Discovery Market in Middle East and North Africa: Distribution by End User

26.4.1. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Pharma and Biotech Companies: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.4.2. Quantum Computing in Drug Discovery Market in Middle East and North Africa for CROs: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

26.4.3. Quantum Computing in Drug Discovery Market in Middle East and North Africa for Research and Academic Institutes: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

+ 27. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET: LATIN AMERICA

27.1. Quantum Computing in Drug Discovery Market in Latin America: Distribution by Type of Offering

27.1.1. Quantum Computing in Drug Discovery Market in Latin America for Hardware: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.1.2. Quantum Computing in Drug Discovery Market in Latin America for Service: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.1.3. Quantum Computing in Drug Discovery Market in Latin America for Platform / Software: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.2. Quantum Computing in Drug Discovery Market in Latin America: Distribution by Drug Discovery Step

27.2.1. Quantum Computing in Drug Discovery Market in Latin America for Target Identification / Validation: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.2.2. Quantum Computing in Drug Discovery Market in Latin America for Hit Generation / Lead Identification: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.2.3. Quantum Computing in Drug Discovery Market in Latin America for Lead Optimization: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3. Quantum Computing in Drug Discovery Market in Latin America: Distribution by Target Therapeutic Area

27.3.1. Quantum Computing in Drug Discovery Market in Latin America for Oncological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.2. Quantum Computing in Drug Discovery Market in Latin America for Cardiovascular Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.3. Quantum Computing in Drug Discovery Market in Latin America for Musculoskeletal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.4. Quantum Computing in Drug Discovery Market in Latin America for Neurological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.5. Quantum Computing in Drug Discovery Market in Latin America for Respiratory Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.6. Quantum Computing in Drug Discovery Market in Latin America for Immunological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.7. Quantum Computing in Drug Discovery Market in Latin America for Gastrointestinal Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.8. Quantum Computing in Drug Discovery Market in Latin America for Endocrine Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.9. Quantum Computing in Drug Discovery Market in Latin America for Ophthalmological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.10. Quantum Computing in Drug Discovery Market in Latin America for Blood-related Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.11. Quantum Computing in Drug Discovery Market in Latin America for Dermatological Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.12. Quantum Computing in Drug Discovery Market in Latin America for Infectious Diseases: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.3.13. Quantum Computing in Drug Discovery Market in Latin America for Urinary Disorders: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.4. Quantum Computing in Drug Discovery Market in Latin America: Distribution by End User

27.4.1. Quantum Computing in Drug Discovery Market in Latin America for Pharma and Biotech Companies: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.4.2. Quantum Computing in Drug Discovery Market in Latin America for CROs: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

27.4.3. Quantum Computing in Drug Discovery Market in Latin America for Research and Academic Institutes: Historical Trends (since 2023) and Forecasted Estimates (till 2035)

**Detailed information on Chapters 23-27 is available in the Excel Data Packs shared along with the report**

+ 28. QUANTUM COMPUTING IN DRUG DISCOVERY MARKET, BY LEADING PLAYERS

28.1. Chapter Overview

28.2. Key Assumptions and Methodology

28.3. Quantum Computing in Drug Discovery Market: Distribution by Leading Players

28.4. Data Triangulation and Validation

+ 29. CONCLUSION

+ 30. EXECUTIVE INSIGHTS

30.1. Chapter Overview

30.2. Company A

30.2.1. Company Snapshot

30.2.2. Interview Transcript: Chief Executive Officer

30.3. Company B

30.3.1. Company Snapshot

30.3.2. Interview Transcript: Quantum Engineer

30.4. Company C

30.4.1. Company Snapshot

30.4.2. Interview Transcript: Manager of Quantum Technologies

30.5. Company D

30.5.1. Company Snapshot

30.5.2. Interview Transcript: Research Scientist

+ 31. APPENDIX I: TABULATED DATA

+ 32. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

+ List of Figures

Figure 2.1 Research Methodology: Project Methodology

Figure 2.2 Research Methodology: Data Sources for Secondary Research

Figure 2.3 Research Methodology: Robust Quality Control

Figure 3.1 Market Dynamics: Forecast Methodology

Figure 3.2 Market Dynamics: Market Assessment Framework

Figure 4.1 Lessons Learnt from Past Recessions

Figure 5.1 Executive Summary: Market Landscape

Figure 5.2 Executive Summary: Market Trends

Figure 5.3 Executive Summary: Market Forecast and Opportunity Analysis

Figure 6.1 Drug Discovery and Development Timeline

Figure 6.2 Historical Evolution of Computational Drug Discovery Approaches

Figure 7.1 Quantum Computing Software Providers: Distribution by Year of Establishment

Figure 7.2 Quantum Computing Software Providers: Distribution by Company Size

Figure 7.3 Quantum Computing Software Providers: Distribution by Location of Headquarters

Figure 7.4 Quantum Computing Software Providers: Distribution by Business Capabilities

Figure 7.5 Quantum Computing Software Providers: Distribution by Type of Service Offered

Figure 7.6 Quantum Computing Software Providers: Distribution by Type of Drug Discovery Service Offered

Figure 7.7 Quantum Computing Software Providers: Distribution by Type of Molecule Compatible

Figure 7.8 Quantum Computing Software Providers: Distribution by Compatible Computational Approach

Figure 7.9 Quantum Computing Software Providers: Distribution by Target Therapeutic Area

Figure 7.10 Quantum Computing Software Providers: Distribution by End User

Figure 8.1 Company Competitiveness Analysis: Peer Groups

Figure 8.2 Company Competitiveness Analysis: Players based in North America (Peer Group I)

Figure 8.3 Company Competitiveness Analysis: Players based in Europe (Peer Group II)

Figure 8.4 Company Competitiveness Analysis: Players based in Asia-Pacific and Rest of the World (Peer Group III)

Figure 9.1 Quantum Computing Hardware Providers: Distribution by Year of Establishment

Figure 9.2 Quantum Computing Hardware Providers: Distribution by Company Size

Figure 9.3 Quantum Computing Hardware Providers: Distribution by Location of Headquarters

Figure 9.4 Quantum Computing Hardware Providers: Distribution by Type of Offering

Figure 9.5 Quantum Computing Hardware Providers: Distribution by Data Storage on Cloud

Figure 9.6 Quantum Computing Hardware Providers: Distribution by Compatible Computational Approaches

Figure 9.7 Quantum Computing Hardware Providers: Distribution by Type of Additional Services Offered

Figure 12.1 Grants: Distribution by Year of Grant

Figure 12.2 Grants: Distribution by Amount Awarded (USD Million)

Figure 12.3 Grants: Distribution by Activity Codes

Figure 12.4 Grants: Distribution by Support Period

Figure 12.5 Grants: Distribution by Purpose of Grant

Figure 12.6 Grants: Distribution by Administering Institute Center

Figure 12.7 Grants: Distribution by Type of Organization

Figure 12.8 Prominent Program Officers: Analysis by Number of Grants

Figure 12.9 Grants: Distribution by Funding Institute Center

Figure 12.10 Grants: Distribution by Type of Grant Application

Figure 12.11 Grants: Distribution by Funding Institute Center and Support Period

Figure 12.12 Grants: Distribution by Location of Recipient Organization

Figure 12.13 Popular Recipient Organizations: Distribution by Amount Awarded (USD Million)

Figure 12.14 Popular Recipient Organizations: Distribution by Number of Grants

Figure 12.15 Grants: Summary

Figure 13.1 Partnerships and Collaborations: Year of Partnerships, Since 2024

Figure 13.2 Partnerships and Collaborations: Distribution by Type of Partnership

Figure 13.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership

Figure 13.4 Partnerships and Collaborations: Distribution by Type of Product Involved

Figure 13.5 Most Active Players: Distribution by Number of Partnerships

Figure 13.6 Partnerships and Collaborations: Local and International Agreements

Figure 13.7 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements

Figure 15.1 Blue Ocean Strategy: Strategy Canvas

Figure 15.2 Blue Ocean Strategy: Pioneer-Migrator-Settler (PMS) Map

Figure 16.1 Porter’s Five Forces: Key Parameters

Figure 17.2 Porter’s Five Forces: Harvey Ball Analysis

Figure 17.1 Global Quantum Computing in Drug Discovery Market, Historical Trends (since 2023) and Forecasted Estimated (till 2035) (USD Million)

Figure 17.2 Global Quantum Computing in Drug Discovery Market, Forecasted Estimates (till 2035): Conservative Scenario (USD Million)

Figure 17.3 Global Quantum Computing in Drug Discovery Market, Forecasted Estimates (till 2035): Optimistic Scenario (USD Million)

Figure 18.1 Quantum Computing in Drug Discovery Market: Distribution by Type of Offering

Figure 18.2 Quantum Computing in Drug Discovery Market for Hardware, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 18.3 Quantum Computing in Drug Discovery Market for Service, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 18.4 Quantum Computing in Drug Discovery Market for Platform / Software, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 19.1 Quantum Computing in Drug Discovery Market: Distribution by Drug Discovery Step

Figure 19.2 Quantum Computing in Drug Discovery Market for Target Identification / Validation, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 19.3 Quantum Computing in Drug Discovery Market for Hit Generation / Lead Identification, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 19.4 Quantum Computing in Drug Discovery Market for Lead Optimization, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.1 Quantum Computing in Drug Discovery Market: Distribution by Target Therapeutic Area

Figure 20.2 Quantum Computing in Drug Discovery Market for Oncological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.3 Quantum Computing in Drug Discovery Market for Musculoskeletal Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.4 Quantum Computing in Drug Discovery Market for Cardiovascular Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.5 Quantum Computing in Drug Discovery Market for Respiratory Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.6 Quantum Computing in Drug Discovery Market for Neurological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.7 Quantum Computing in Drug Discovery Market for Gastrointestinal Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.8 Quantum Computing in Drug Discovery Market for Immunological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.9 Quantum Computing in Drug Discovery Market for Endocrine Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.10 Quantum Computing in Drug Discovery Market for Ophthalmological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.11 Quantum Computing in Drug Discovery Market for Blood-related Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.12 Quantum Computing in Drug Discovery Market for Dermatological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.13 Quantum Computing in Drug Discovery Market for Infectious Diseases, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 20.14 Quantum Computing in Drug Discovery Market for Urinary Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 21.1 Quantum Computing in Drug Discovery Market: Distribution by End User

Figure 21.2 Quantum Computing in Drug Discovery Market for Pharma and Biotech Companies, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 21.3 Quantum Computing in Drug Discovery Market for CROs, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 21.4 Quantum Computing in Drug Discovery Market for Research and Academic Institutes, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.1 Quantum Computing in Drug Discovery Market: Distribution by Geographical Regions

Figure 22.2 Quantum Computing in Drug Discovery Market in North America, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.3 Quantum Computing in Drug Discovery Market in the US, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.4 Quantum Computing in Drug Discovery Market in Canada, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.5 Quantum Computing in Drug Discovery Market in Puerto Rico, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.6 Quantum Computing in Drug Discovery Market in Europe, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.7 Quantum Computing in Drug Discovery Market in the UK, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.8 Quantum Computing in Drug Discovery Market in Germany, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.9 Quantum Computing in Drug Discovery Market in France, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.10 Quantum Computing in Drug Discovery Market in Italy, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.11 Quantum Computing in Drug Discovery Market in Spain, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.12 Quantum Computing in Drug Discovery Market in Rest of Europe, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.13 Quantum Computing in Drug Discovery Market in Asia-Pacific, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.14 Quantum Computing in Drug Discovery Market in China, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.15 Quantum Computing in Drug Discovery Market in Japan, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.16 Quantum Computing in Drug Discovery Market in Australia, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.17 Quantum Computing in Drug Discovery Market in South Korea, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.18 Quantum Computing in Drug Discovery Market in India, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.19 Quantum Computing in Drug Discovery Market in Middle East and North Africa, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.20 Quantum Computing in Drug Discovery Market in Saudi Arabia, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.21 Quantum Computing in Drug Discovery Market in UAE, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.22 Quantum Computing in Drug Discovery Market in Egypt, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.23 Quantum Computing in Drug Discovery Market in Latin America, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.24 Quantum Computing in Drug Discovery Market in Brazil, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.25 Quantum Computing in Drug Discovery Market in Mexico, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.26 Quantum Computing in Drug Discovery Market in Argentina, Historical Trends (since 2023) and Forecasted Estimates (till 2035) (USD Million)

Figure 22.27 Quantum Computing in Drug Discovery Market: Market Movement Analysis

Figure 22.28 Quantum Computing in Drug Discovery Market: Penetration-Growth (P-G) Matrix

Figure 28.1 Quantum Computing in Drug Discovery Market: Distribution by Leading Players

+ List of Tables

Table 7.1 List of Quantum Computing Software Providers

Table 7.2 Quantum Computing Software Providers: Information on Type of Service Offered, Type of Drug Discovery Service Offered, Type of Compatible Molecule, Compatible Computational Approach, Target Therapeutic Area, End User

Table 9.1 List of Quantum Computing Hardware Providers

Table 9.2 Quantum Computing Hardware Providers: Information on Availability of Data Storage on Cloud, Compatible Computational Approach, Type of Additional Service Offered

Table 10.1 Accenture: Service Portfolio

Table 10.2 Accenture: Key Initiatives

Table 10.3 Atos: Service Portfolio

Table 10.4 Atos: Key Initiatives

Table 10.5 Eviden: Service Portfolio

Table 10.6 Eviden: Key Initiatives

Table 10.7 Huawei: Service Portfolio

Table 10.8 Huawei: Key Initiatives

Table 10.9 Tencent Cloud: Service Portfolio

Table 10.10 Tencent Cloud: Key Initiatives

Table 10.11 Toshiba: Service Portfolio

Table 10.12 Toshiba: Key Initiatives

Table 11.1 Amazon Web Series (AWS): Service Portfolio

Table 11.2 Amazon Web Series (AWS): Key Initiatives

Table 11.3 Fujitsu: Service Portfolio

Table 11.4 Fujitsu: Key Initiatives

Table 11.5 Google: Service Portfolio

Table 11.6 Google: Key Initiatives

Table 11.7 IBM: Service Portfolio

Table 11.8 IBM: Key Initiatives

Table 11.9 Microsoft: Service Portfolio

Table 11.10 Microsoft: Key Initiatives

Table 12.1 Quantum Computing in Drug Discovery: List of Grants (Since 2021)

Table 13.1 Quantum Computing Market in Drug Discovery: List of Partnerships and Collaborations, Since 2024

Table 13.2 Quantum Computing Market in Drug Discovery: Information on Location of Headquarters (Country / Region) and Type of Agreement (Country / Region)

Table 31.1 Quantum Computing Software Providers: Distribution by Year of Establishment

Table 31.2 Quantum Computing Software Providers: Distribution by Company Size

Table 31.3 Quantum Computing Software Providers: Distribution by Location of Headquarters

Table 31.4 Quantum Computing Software Providers: Distribution by Business Capabilities

Table 31.5 Quantum Computing Software Providers: Distribution by Type of Service Offered

Table 31.6 Quantum Computing Software Providers: Distribution by Type of Drug Discovery Service Offered

Table 31.7 Quantum Computing Software Providers: Distribution by Type of Molecule Compatible

Table 31.8 Quantum Computing Software Providers: Distribution by Compatible Computational Approach

Table 31.9 Quantum Computing Software Providers: Distribution by Target Therapeutic Area

Table 31.10 Quantum Computing Software Providers: Distribution by End User

Table 31.11 Company Competitiveness Analysis: Peer Groups

Table 31.12 Quantum Computing Hardware Providers: Distribution by Year of Establishment

Table 31.13 Quantum Computing Hardware Providers: Distribution by Company Size

Table 31.14 Quantum Computing Hardware Providers: Distribution by Location of Headquarters

Table 31.15 Quantum Computing Hardware Providers: Distribution by Type of Offering

Table 31.16 Quantum Computing Hardware Providers: Distribution by Data Storage on Cloud

Table 31.17 Quantum Computing Hardware Providers: Distribution by Compatible Computational Approaches

Table 31.18 Quantum Computing Hardware Providers: Distribution by Type of Additional Services Offered

Table 31.19 Grants: Distribution by Year of Grant

Table 31.20 Grants: Distribution by Amount Awarded (USD Million)

Table 31.21 Grants: Distribution by Activity Codes

Table 31.22 Grants: Distribution by Support Period

Table 31.23 Grants: Distribution by Purpose of Grant

Table 31.24 Grants: Distribution by Administering Institute Center

Table 31.25 Grants: Distribution by Type of Organization

Table 31.26 Prominent Program Officers: Analysis by Number of Grants

Table 31.27 Grants: Distribution by Funding Institute Center

Table 31.28 Grants: Distribution by Type of Grant Application

Table 31.29 Grants: Distribution by Funding Institute Center and Support Period

Table 31.30 Grants: Distribution by Location of Recipient Organization

Table 31.31 Popular Recipient Organizations: Distribution by Amount Awarded

Table 31.32 Popular Recipient Organizations: Distribution by Number of Grants

Table 31.33 Grants: Summary

Table 31.34 Partnerships and Collaborations: Year of Partnerships, Since 2024

Table 31.35 Partnerships and Collaborations: Distribution by Type of Partnership

Table 31.36 Partnerships and Collaborations: Distribution by Year and Type of Partnership

Table 31.37 Partnerships and Collaborations: Distribution by Type of Product Involved

Table 31.38 Most Active Players: Distribution by Number of Partnerships

Table 31.39 Partnerships and Collaborations: Local and International Agreements

Table 31.40 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements

Table 31.41 Global Quantum Computing in Drug Discovery Market, Historical Trends (since 2023) and Forecasted Estimated (till 2035) (USD Million)

Table 31.42 Global Quantum Computing in Drug Discovery Market, Forecasted Estimates (till 2035): Conservative Scenario (USD Million)

Table 31.43 Global Quantum Computing in Drug Discovery Market, Forecasted Estimates (till 2035): Optimistic Scenario (USD Million)

Table 31.44 Quantum Computing in Drug Discovery Market: Distribution by Type of Offering

Table 31.45 Quantum Computing in Drug Discovery Market for Hardware, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.46 Quantum Computing in Drug Discovery Market for Service, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.47 Quantum Computing in Drug Discovery Market for Platform / Software, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.48 Quantum Computing in Drug Discovery Market: Distribution by Drug Discovery Step

Table 31.49 Quantum Computing in Drug Discovery Market for Target Identification / Validation, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.50 Quantum Computing in Drug Discovery Market for Hit Generation / Lead Identification, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.51 Quantum Computing in Drug Discovery Market for Lead Optimization, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.52 Quantum Computing in Drug Discovery Market: Distribution by Target Therapeutic Area

Table 31.53 Quantum Computing in Drug Discovery Market for Oncological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.54 Quantum Computing in Drug Discovery Market for Musculoskeletal Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.55 Quantum Computing in Drug Discovery Market for Cardiovascular Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.56 Quantum Computing in Drug Discovery Market for Respiratory Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.57 Quantum Computing in Drug Discovery Market for Neurological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.58 Quantum Computing in Drug Discovery Market for Gastrointestinal Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.59 Quantum Computing in Drug Discovery Market for Immunological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.60 Quantum Computing in Drug Discovery Market for Endocrine Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.61 Quantum Computing in Drug Discovery Market for Ophthalmological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.62 Quantum Computing in Drug Discovery Market for Blood-related Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.63 Quantum Computing in Drug Discovery Market for Dermatological Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.64 Quantum Computing in Drug Discovery Market for Infectious Diseases, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.65 Quantum Computing in Drug Discovery Market for Urinary Disorders, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.66 Quantum Computing in Drug Discovery Market: Distribution by End User

Table 31.67 Quantum Computing in Drug Discovery Market for Pharma and Biotech Companies, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.68 Quantum Computing in Drug Discovery Market for CROs, Historical Trends (since 2023), Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.69 Quantum Computing in Drug Discovery Market for Research and Academic Institutes, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.70 Quantum Computing in Drug Discovery Market: Distribution by Geographical Regions

Table 31.71 Quantum Computing in Drug Discovery Market in North America, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.72 Quantum Computing in Drug Discovery Market in the US, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.73 Quantum Computing in Drug Discovery Market in Canada, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.74 Quantum Computing in Drug Discovery Market in Puerto Rico, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.75 Quantum Computing in Drug Discovery Market in Europe, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.76 Quantum Computing in Drug Discovery Market in the UK, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.77 Quantum Computing in Drug Discovery Market in Germany, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.78 Quantum Computing in Drug Discovery Market in France, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.79 Quantum Computing in Drug Discovery Market in Italy, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.80 Quantum Computing in Drug Discovery Market in Spain, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.81 Quantum Computing in Drug Discovery Market in Rest of Europe, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.82 Quantum Computing in Drug Discovery Market in Asia-Pacific, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.83 Quantum Computing in Drug Discovery Market in China, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.84 Quantum Computing in Drug Discovery Market in Japan, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.85 Quantum Computing in Drug Discovery Market in Australia, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.86 Quantum Computing in Drug Discovery Market in South Korea, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.87 Quantum Computing in Drug Discovery Market in India, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.88 Quantum Computing in Drug Discovery Market in Middle East and North Africa, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.89 Quantum Computing in Drug Discovery Market in Saudi Arabia, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.90 Quantum Computing in Drug Discovery Market in UAE, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.91 Quantum Computing in Drug Discovery Market in Egypt, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.92 Quantum Computing in Drug Discovery Market in Latin America, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.93 Quantum Computing in Drug Discovery Market in Brazil, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.94 Quantum Computing in Drug Discovery Market in Mexico, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.95 Quantum Computing in Drug Discovery Market in Argentina, Historical Trends (since 2023) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)

Table 31.96 Quantum Computing in Drug Discovery Market: Distribution by Leading Players

Quantum Computing in Drug Discovery Market